Autoimmune hemolytic anemia after treatment with fingolimod in a patient with multiple sclerosis (MS): A case report and review of the literature

Autoimmun Rev. 2022 Dec;21(12):103203. doi: 10.1016/j.autrev.2022.103203. Epub 2022 Oct 8.

¹ Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran; School of medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
² Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
³ Department of Neurology, Johns Hopkins University, Baltimore, MD, United States. Electronic address: mghajar2@jhmi.edu.
⁴ Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran; Department of Neurology, Isfahan University of Medical Sciences, Isfahan, Iran.

No abstract available

Keywords: Autoimmune hemolytic anemia; Fingolimod; Multiple sclerosis.

Publication types